Tuberculosis in the 1990s: Resurgence, regimens, and resources

R. E. Pust

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Physicians in the United States must maintain vigilance for the 25 000 annual new cases of tuberculosis, concentrated in the elderly, in immigrants, in migrant and minority populations, and in immunosuppressed patients. Tuberculosis rates in the South remain above the national average. Physicians diagnosing tuberculosis may also treat the disease, working with health departments, which can assist with drugs, follow-up tests, and contact investigation. Powerful short-course regimens have been standard treatments since 1986. The preferred combination is isoniazid, rifampin, and pyrazinamide daily for 2 months, followed by isoniazid and rifampin for 4 more months. A 9-month regimen of isoniazid and rifampin is equally effective. Supplementation or extension of these regimens is mandatory when drug resistance or immunosuppression, respectively, is likely. Isoniazid prophylaxis for 6 to 12 months continues to be a vital but often neglected preventive measure for those infected with Mycobacterium tuberculosis, but without active disease.

Original languageEnglish (US)
Pages (from-to)584-593
Number of pages10
JournalSouthern Medical Journal
Issue number6
StatePublished - 1992

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Tuberculosis in the 1990s: Resurgence, regimens, and resources'. Together they form a unique fingerprint.

Cite this